Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Ischemic Heart Disease

  Free Subscription

Articles published in Prog Cardiovasc Dis

Retrieve available abstracts of 84 articles:
HTML format

Single Articles

    July 2021
  1. BELTRAN-GARCIA J, Osca-Verdegal R, Nacher-Sendra E, Cardona-Monzonis A, et al
    Role of non-coding RNAs as biomarkers of deleterious cardiovascular effects in sepsis.
    Prog Cardiovasc Dis. 2021 Jul 12. pii: S0033-0620(21)00073.
    PubMed     Abstract available

  2. ROZENBAUM Z, Takahashi T, Kobayashi Y, Bliagos D, et al
    Contemporary technologies to modify calcified plaque in coronary artery disease.
    Prog Cardiovasc Dis. 2021 Jul 9. pii: S0033-0620(21)00071.
    PubMed     Abstract available

  3. REED JL, Teradaca T, Cotie LM, Tulloch HE, et al
    The effects of high-intensity interval training, Nordic walking and moderate-to-vigorous intensity continuous training on functional capacity, depression and quality of life in patients with coronary artery disease enrolled in cardiac rehabilitation:
    Prog Cardiovasc Dis. 2021 Jul 7. pii: S0033-0620(21)00070.
    PubMed     Abstract available

    June 2021
  4. RUSCICA M, Penson PE, Ferri N, Sirtori CR, et al
    Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases - A position paper from the International Lipid Expert Panel (ILEP).
    Prog Cardiovasc Dis. 2021 Jun 26. pii: S0033-0620(21)00068.
    PubMed     Abstract available

    March 2021
  5. PATEL RAG, White CJ
    Brachiocephalic and subclavian stenosis: Current concepts for cardiovascular specialists.
    Prog Cardiovasc Dis. 2021 Mar 17. pii: S0033-0620(21)00032.
    PubMed     Abstract available

    February 2021
  6. KRITTANAWONG C, Mahtta D, Narasimhan B, Wang Z, et al
    Clinical characteristics and mortality after acute myocardial infarction-related hospitalization among Asians from a national population-based cohort study.
    Prog Cardiovasc Dis. 2021 Feb 2. pii: S0033-0620(21)00015.

    January 2021
  7. NARASIMHAN B, Kaplin SL, Narasimhan H, Wang Z, et al
    Trends in pneumococcal vaccination in patients presenting with acute coronary syndrome in the United States.
    Prog Cardiovasc Dis. 2021 Jan 9. pii: S0033-0620(21)00002.

    Editor-in-chief eight years at Progress in Cardiovascular Diseases.
    Prog Cardiovasc Dis. 2021;64:138-139.

    December 2020
  9. WILLIAMSON TM, Moran C, McLennan A, Seidel S, et al
    Promoting adherence to physical activity among individuals with cardiovascular disease using behavioral counseling: A theory and research-based primer for health care professionals.
    Prog Cardiovasc Dis. 2020 Dec 29. pii: S0033-0620(20)30209.
    PubMed     Abstract available

    November 2020
  10. MEHTA A, Kondamudi N, Laukkanen JA, Wisloff U, et al
    Running away from cardiovascular disease at the right speed: The impact of aerobic physical activity and cardiorespiratory fitness on cardiovascular disease risk and associated subclinical phenotypes.
    Prog Cardiovasc Dis. 2020 Nov 12. pii: S0033-0620(20)30184.
    PubMed     Abstract available

  11. CASTAGNA C, Krustrup P, Povoas S
    Cardiovascular fitness and health effects of various types of team sports for adult and elderly inactive individuals - a brief narrative review.
    Prog Cardiovasc Dis. 2020;63:709-722.
    PubMed     Abstract available

    September 2020
  12. LETNES JM, Dalen H, Aspenes ST, Salvesen O, et al
    Age-related change in peak oxygen uptake and change of cardiovascular risk factors. The HUNT study.
    Prog Cardiovasc Dis. 2020 Sep 21. pii: S0033-0620(20)30159.
    PubMed     Abstract available

  13. TEHRANI BN, Basir MB, Kapur NK
    Acute myocardial infarction and cardiogenic shock: Should we unload the ventricle before percutaneous coronary intervention?
    Prog Cardiovasc Dis. 2020 Sep 10. pii: S0033-0620(20)30157.
    PubMed     Abstract available

    August 2020
  14. UTH J, Fristrup B, Sorensen V, Helge EW, et al
    Exercise intensity and cardiovascular health outcomes after 12months of football fitness training in women treated for stage I-III breast cancer: Results from the football fitness After Breast Cancer (ABC) randomized controlled trial.
    Prog Cardiovasc Dis. 2020 Aug 12. pii: S0033-0620(20)30154.
    PubMed     Abstract available

    July 2020
  15. LAVIE CJ
    Statistics 2020 at progress in cardiovascular diseases.
    Prog Cardiovasc Dis. 2020 Jul 30. pii: S0033-0620(20)30145.

  16. SEABRA A, Brito J, Figueiredo P, Beirao L, et al
    School-based soccer practice is an effective strategy to improve cardiovascular and metabolic risk factors in overweight children.
    Prog Cardiovasc Dis. 2020 Jul 25. pii: S0033-0620(20)30144.
    PubMed     Abstract available

  17. FREUND A, Desch S, Thiele H
    Intra-aortic balloon counterpulsation - Does it work?
    Prog Cardiovasc Dis. 2020 Jul 5. pii: S0033-0620(20)30138.
    PubMed     Abstract available

    June 2020
  18. LARSEN MN, Madsen M, Nielsen CM, Manniche V, et al
    Cardiovascular adaptations after 10months of daily 12-min bouts of intense school-based physical training for 8-10-year-old children.
    Prog Cardiovasc Dis. 2020 Jun 1. pii: S0033-0620(20)30119.
    PubMed     Abstract available

    May 2020
  19. YOUSUF T, Nakhle A, Rawal H, Harrison D, et al
    Natural disasters and acute myocardial infarction.
    Prog Cardiovasc Dis. 2020 May 14. pii: S0033-0620(20)30099.
    PubMed     Abstract available

  20. DESAI AS, Kamdar BB, Mehra MR
    Palliative care considerations for cardiovascular clinicians in COVID-19.
    Prog Cardiovasc Dis. 2020 May 8. pii: S0033-0620(20)30098.

  21. KRITTANAWONG C, Virk HUH, Narasimhan B, Wang Z, et al
    Coronavirus disease 2019 (COVID-19) and cardiovascular risk: A meta-analysis.
    Prog Cardiovasc Dis. 2020 May 7. pii: S0033-0620(20)30097.

  22. LIPPI G, Lavie CJ, Sanchis-Gomar F
    Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis.
    Prog Cardiovasc Dis. 2020;63:390-391.

    April 2020
  23. ZHOU K, Yang S, Jia P
    Towards precision management of cardiovascular patients with COVID-19 to reduce mortality.
    Prog Cardiovasc Dis. 2020 Apr 27. pii: S0033-0620(20)30084.

  24. SANTOS HO, Earnest CP, Tinsley GM, Izidoro LFM, et al
    Small dense low-density lipoprotein-cholesterol (sdLDL-C): Analysis, effects on cardiovascular endpoints and dietary strategies.
    Prog Cardiovasc Dis. 2020 Apr 27. pii: S0033-0620(20)30081.
    PubMed     Abstract available

  25. KARIO K, Ferdinand KC, O'Keefe JH
    Control of 24-hour blood pressure with SGLT2 inhibitors to prevent cardiovascular disease.
    Prog Cardiovasc Dis. 2020 Apr 7. pii: S0033-0620(20)30074.
    PubMed     Abstract available

  26. GARG A, Rout A, Sharma A, Sargsyan D, et al
    Safety and efficacy of antiplatelet regimens after percutaneous coronary intervention using drug eluting stents: A network meta-analysis of randomized controlled trials.
    Prog Cardiovasc Dis. 2020 Apr 2. pii: S0033-0620(20)30072.
    PubMed     Abstract available

    March 2020
  27. DAS A, Roy B, Bandyopadhyay D, Dasgupta S, et al
    Non-statin interventions in the prevention of cardiovascular events: Sex-based meta-analysis.
    Prog Cardiovasc Dis. 2020 Mar 26. pii: S0033-0620(20)30064.
    PubMed     Abstract available

  28. LAVIE CJ
    Special assorted cardiovascular topics.
    Prog Cardiovasc Dis. 2020 Mar 26. pii: S0033-0620(20)30070.

  29. GERSH F
    Benefits of estrogen in cardiovascular diseases.
    Prog Cardiovasc Dis. 2020 Mar 21. pii: S0033-0620(20)30062.

  30. XU B, Kocyigit D, Griffin BP, Cheng F, et al
    Applications of artificial intelligence in multimodality cardiovascular imaging: A state-of-the-art review.
    Prog Cardiovasc Dis. 2020 Mar 19. pii: S0033-0620(20)30060.
    PubMed     Abstract available

  31. GULLO AL, Rodriguez-Carrio J, Gallizzi R, Imbalzano E, et al
    Speckle tracking echocardiography as a new diagnostic tool for an assessment of cardiovascular disease in rheumatic patients.
    Prog Cardiovasc Dis. 2020 Mar 19. pii: S0033-0620(20)30057.
    PubMed     Abstract available

    February 2020
  32. HAMILTON AB, Brown A, Loeb T, Chin D, et al
    Enhancing patient and organizational readiness for cardiovascular risk reduction among black and Latinx patients living with HIV: Study protocol.
    Prog Cardiovasc Dis. 2020 Feb 25. pii: S0033-0620(20)30054.
    PubMed     Abstract available

  33. AIFAH A, Okeke NL, Rentrope CR, Schexnayder J, et al
    Use of a human-centered design approach to adapt a nurse-led cardiovascular disease prevention intervention in HIV clinics.
    Prog Cardiovasc Dis. 2020 Feb 21. pii: S0033-0620(20)30053.
    PubMed     Abstract available

  34. LONGENECKER CT, Webel AR, Lloyd-Jones DM
    Prevention as treatment: A bold vision for improving the cardiovascular health of people living with HIV.
    Prog Cardiovasc Dis. 2020 Feb 20. pii: S0033-0620(20)30051.

  35. TAKADA S, Ober AJ, Currier JS, Goldstein NJ, et al
    Reducing cardiovascular risk among people living with HIV: Rationale and design of the INcreasing Statin Prescribing in HIV Behavioral Economics REsearch (INSPIRE) randomized controlled trial.
    Prog Cardiovasc Dis. 2020 Feb 18. pii: S0033-0620(20)30052.
    PubMed     Abstract available

  36. MANGIACAPRA F, Del Buono MG, Abbate A, Gori T, et al
    Role of endothelial dysfunction in determining angina after percutaneous coronary intervention: Learning from pathophysiology to optimize treatment.
    Prog Cardiovasc Dis. 2020 Feb 13. pii: S0033-0620(20)30039.
    PubMed     Abstract available

  37. MUIRURI C, Longenecker CT, Meissner EG, Okeke NL, et al
    Prevention of cardiovascular disease for historically marginalized racial and ethnic groups living with HIV: A narrative review of the literature.
    Prog Cardiovasc Dis. 2020 Feb 11. pii: S0033-0620(20)30036.
    PubMed     Abstract available

  38. OKELLO S, Amir A, Bloomfield GS, Kentoffio K, et al
    Prevention of cardiovascular disease among people living with HIV in sub-Saharan Africa.
    Prog Cardiovasc Dis. 2020 Feb 5. pii: S0033-0620(20)30034.
    PubMed     Abstract available

  39. WILLIAMS SK, Johnson BA, Tobin JN, Luque AE, et al
    Protocol paper: Stepped wedge cluster randomized trial translating the ABCS into optimizing cardiovascular care for people living with HIV.
    Prog Cardiovasc Dis. 2020 Feb 5. pii: S0033-0620(20)30033.
    PubMed     Abstract available

    January 2020
  40. OZEMEK C, Erlandson KM, Jankowski CM
    Physical activity and exercise to improve cardiovascular health for adults living with HIV.
    Prog Cardiovasc Dis. 2020 Jan 31. pii: S0033-0620(20)30027.
    PubMed     Abstract available

    November 2019
  41. MARTINEZ-GOMEZ D, Lavie CJ, Hamer M, Cabanas-Sanchez V, et al
    Physical activity without weight loss reduces the development of cardiovascular disease risk factors - a prospective cohort study of more than one hundred thousand adults.
    Prog Cardiovasc Dis. 2019 Nov 20. pii: S0033-0620(19)30144.
    PubMed     Abstract available

  42. DZAYE O, Dudum R, Reiter-Brennan C, Kianoush S, et al
    Coronary artery calcium scoring for individualized cardiovascular risk estimation in important patient subpopulations after the 2019 AHA/ACC primary prevention guidelines.
    Prog Cardiovasc Dis. 2019 Nov 9. pii: S0033-0620(19)30132.
    PubMed     Abstract available

    October 2019
  43. MINAME MH, Santos RD
    Reducing cardiovascular risk in patients with familial hypercholesterolemia: Risk prediction and lipid management.
    Prog Cardiovasc Dis. 2019 Oct 25. pii: S0033-0620(19)30128.
    PubMed     Abstract available

    September 2019
  44. LAUKKANEN JA, Kunutsor SK, Ozemek C, Makikallio T, et al
    Cross-country skiing and running's association with cardiovascular events and all-cause mortality: A review of the evidence.
    Prog Cardiovasc Dis. 2019 Sep 7. pii: S0033-0620(19)30110.
    PubMed     Abstract available

    August 2019
    Emerging strategies for diabetes and cardiovascular disorders: Introduction and foreword.
    Prog Cardiovasc Dis. 2019 Aug 27. pii: S0033-0620(19)30109.

  46. ACHARYA T, Deedwania P
    Cardiovascular outcome trials of the newer anti-diabetic medications.
    Prog Cardiovasc Dis. 2019 Aug 20. pii: S0033-0620(19)30106.
    PubMed     Abstract available

  47. GARG V, Verma S, Connelly K
    Mechanistic insights regarding the role of SGLT2 inhibitors and GLP1 agonist drugs on cardiovascular disease in diabetes.
    Prog Cardiovasc Dis. 2019 Aug 2. pii: S0033-0620(19)30102.
    PubMed     Abstract available

  48. GODOY LC, Ko DT, Rao V, Farkouh ME, et al
    The Role of Coronary Artery Bypass Surgery Versus Percutaneous Intervention in Patients with Diabetes and Coronary Artery Disease.
    Prog Cardiovasc Dis. 2019 Aug 1. pii: S0033-0620(19)30101.
    PubMed     Abstract available

    July 2019
  49. LAVIE CJ
    Continuing with Good Statistics at Progress in Cardiovascular Diseases.
    Prog Cardiovasc Dis. 2019 Jul 11. pii: S0033-0620(19)30099.

  50. NELSON AJ, Peterson ED, Pagidipati NJ
    Atherosclerotic cardiovascular disease and heart failure: Determinants of risk and outcomes in patients with diabetes.
    Prog Cardiovasc Dis. 2019 Jul 10. pii: S0033-0620(19)30098.
    PubMed     Abstract available

  51. GUPTA M, Tummala R, Ghosh RK, Blumenthal C, et al
    An update on pharmacotherapies in diabetic dyslipidemia.
    Prog Cardiovasc Dis. 2019;62:334-341.
    PubMed     Abstract available

    May 2019
  52. BOB-MANUEL T, Jenkins JS, Morin DP
    Non-arrhythmic causes of sudden death: A comprehensive review.
    Prog Cardiovasc Dis. 2019;62:265-271.
    PubMed     Abstract available

    February 2019
  53. NAUMAN J, Nes BM, Zisko N, Revdal A, et al
    Personal activity intelligence (PAI): A new standard in activity tracking for obtaining a healthy cardiorespiratory fitness level and low cardiovascular risk.
    Prog Cardiovasc Dis. 2019 Feb 21. pii: S0033-0620(19)30039.
    PubMed     Abstract available

  54. KIRKHAM AA, Beaudry RI, Paterson DI, Mackey JR, et al
    Curing breast Cancer and killing the heart: A novel model to explain elevated cardiovascular disease and mortality risk among women with early stage breast Cancer.
    Prog Cardiovasc Dis. 2019 Feb 21. pii: S0033-0620(19)30034.
    PubMed     Abstract available

    January 2019
  55. KAMINSKY LA, Arena R, Ellingsen O, Harber MP, et al
    Cardiorespiratory Fitness and Cardiovascular Disease - the Past, Present, and Future.
    Prog Cardiovasc Dis. 2019 Jan 9. pii: S0033-0620(19)30002.
    PubMed     Abstract available

    November 2018
  56. OZEMEK C, Laddu DR, Lavie CJ, Claeys H, et al
    An Update on the Role of Cardiorespiratory Fitness, Structured Exercise and Lifestyle Physical Activity in Preventing Cardiovascular Disease and Health Risk.
    Prog Cardiovasc Dis. 2018 Nov 13. pii: S0033-0620(18)30220.
    PubMed     Abstract available

    July 2018
  57. AWERBACH JD, Krasuski RA, Camitta MGW
    Coronary Disease and Modifying Cardiovascular Risk in Adult Congenital Heart Disease Patients: Should General Guidelines Apply?
    Prog Cardiovasc Dis. 2018 Jul 21. pii: S0033-0620(18)30151.
    PubMed     Abstract available

  58. ELAGIZI A, Kachur S, Lavie CJ, Carbone S, et al
    An Overview and Update on Obesity and the Obesity Paradox in Cardiovascular Diseases.
    Prog Cardiovasc Dis. 2018 Jul 5. pii: S0033-0620(18)30130.
    PubMed     Abstract available

  59. BARRY VW, Caputo JL, Kang M
    The Joint Association of Fitness and Fatness on Cardiovascular Disease Mortality: A Meta-Analysis.
    Prog Cardiovasc Dis. 2018 Jul 4. pii: S0033-0620(18)30131.
    PubMed     Abstract available

  60. RUIZ JR, Martinez-Tellez B, Sanchez-Delgado G, Osuna-Prieto FJ, et al
    Role of Human Brown Fat in Obesity, Metabolism and Cardiovascular Disease: Strategies to Turn Up the Heat.
    Prog Cardiovasc Dis. 2018 Jul 4. pii: S0033-0620(18)30129.
    PubMed     Abstract available

  61. ORTEGA FB, Lavie CJ
    Introduction and Update on Obesity and Cardiovascular Diseases 2018.
    Prog Cardiovasc Dis. 2018 Jul 4. pii: S0033-0620(18)30137.

    June 2018
  62. PICHE ME, Poirier P, Lemieux I, Despres JP, et al
    Overview of Epidemiology and Contribution of Obesity and Body Fat Distribution to Cardiovascular Disease: An Update.
    Prog Cardiovasc Dis. 2018 Jun 28. pii: S0033-0620(18)30122.
    PubMed     Abstract available

  63. ENGLISH WJ, Williams DB
    Metabolic and Bariatric Surgery: An Effective Treatment Option for Obesity and Cardiovascular Disease.
    Prog Cardiovasc Dis. 2018 Jun 25. pii: S0033-0620(18)30121.
    PubMed     Abstract available

    May 2018
  64. CHIAVAROLI L, Nishi SK, Khan TA, Braunstein CR, et al
    Portfolio Dietary Pattern and Cardiovascular Disease: A Systematic Review and Meta-Analysis of Controlled Trials.
    Prog Cardiovasc Dis. 2018 May 25. pii: S0033-0620(18)30094.
    PubMed     Abstract available

  65. KAHLEOVA H, Levin S, Barnard ND
    Vegetarian Dietary Patterns and Cardiovascular Disease.
    Prog Cardiovasc Dis. 2018 May 22. pii: S0033-0620(18)30087.
    PubMed     Abstract available

  66. BITOK E, Sabate J
    Nuts and Cardiovascular Disease.
    Prog Cardiovasc Dis. 2018 May 22. pii: S0033-0620(18)30092.
    PubMed     Abstract available

    Dietary Prevention of Cardiovascular Diseases.
    Prog Cardiovasc Dis. 2018 May 4. pii: S0033-0620(18)30085.

    April 2018
  68. SALAS-SALVADO J, Becerra-Tomas N, Garcia-Gavilan JF, Bullo M, et al
    Mediterranean Diet and Cardiovascular Disease Prevention: What do We Know?
    Prog Cardiovasc Dis. 2018 Apr 17. pii: S0033-0620(18)30074.
    PubMed     Abstract available

  69. KIM ESH, Beckman JA
    Introduction to the Vascular Medicine Issue of Progress in Cardiovascular Diseases.
    Prog Cardiovasc Dis. 2018 Apr 6. pii: S0033-0620(18)30069.

  70. AGRAWAL V, Kim ESH
    Spontaneous Coronary Artery Dissection: Cardiac Manifestations of Vascular Disease.
    Prog Cardiovasc Dis. 2018 Apr 6. pii: S0033-0620(18)30067.
    PubMed     Abstract available

    March 2018
  71. ELAGIZI A, Lavie CJ, Marshall K, DiNicolantonio JJ, et al
    Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Health: A Comprehensive Review.
    Prog Cardiovasc Dis. 2018 Mar 20. pii: S0033-0620(18)30061.
    PubMed     Abstract available

    February 2018
  72. KERNEIS M, Talib U, Nafee T, Daaboul Y, et al
    Triple antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Prog Cardiovasc Dis. 2018 Feb 2. pii: S0033-0620(18)30028.
    PubMed     Abstract available

    January 2018
  73. EFFRON MB, Gibson CM
    The waxing and waning of antithrombotic therapy in cardiovascular disease - Where is the moon now?
    Prog Cardiovasc Dis. 2018 Jan 21. pii: S0033-0620(18)30032.

    Thiamine and cardiovascular disease: A literature review.
    Prog Cardiovasc Dis. 2018 Jan 19. pii: S0033-0620(18)30029.
    PubMed     Abstract available

  75. TANTRY U, Navarese EP, Myat A, Gurbel P, et al
    Selection of P2Y12 inhibitor in percutaneous coronary intervention and/or acute coronary syndrome.
    Prog Cardiovasc Dis. 2018 Jan 12. pii: S0033-0620(18)30020.
    PubMed     Abstract available

  76. ZEITOUNI M, Kerneis M, Nafee T, Collet JP, et al
    Anticoagulation in acute coronary syndrome-state of the art.
    Prog Cardiovasc Dis. 2018 Jan 12. pii: S0033-0620(18)30021.
    PubMed     Abstract available

  77. VIDULA MK, Secemsky EA, Yeh RW
    Duration of Dual Antiplatelet Therapy for Stented Patients: An Update for the Clinician.
    Prog Cardiovasc Dis. 2018;60.
    PubMed     Abstract available

  78. EFFRON MB, Gibson CM
    Dual (Anticoagulant Plus Single Antiplatelet) vs Triple (Anticoagulant Plus Dual Antiplatelet) Antithrombotic Therapy - "Real World" Experience.
    Prog Cardiovasc Dis. 2018;60.
    PubMed     Abstract available

  79. GOLWALA H, Bhatt DL
    The Timing of P2Y12 Inhibitor Initiation in the Treatment of ACS? Does the Evidence Exist in This Era?
    Prog Cardiovasc Dis. 2018;60.
    PubMed     Abstract available

    December 2017
  80. SARBACKER GB, Lusk KA, Kalich B
    Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease in Adults 80-Years-of-Age and Older.
    Prog Cardiovasc Dis. 2017 Dec 29. pii: S0033-0620(17)30168.

  81. MOON JY, Franchi F, Rollini F, Angiolillo DJ, et al
    Evolution of Coronary Stent Technology and Implications for Duration of Dual Antiplatelet Therapy.
    Prog Cardiovasc Dis. 2017 Dec 29. pii: S0033-0620(17)30166.
    PubMed     Abstract available

  82. SHARMA A, Garg A, Elmariah S, Drachman D, et al
    Duration of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation in Diabetic and Non-Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Prog Cardiovasc Dis. 2017 Dec 22. pii: S0033-0620(17)30165.
    PubMed     Abstract available

    November 2017
  83. KARIO K, Tomitani N, Kanegae H, Yasui N, et al
    Development of a New ICT-Based Multisensor Blood Pressure Monitoring System for Use in Hemodynamic Biomarker-Initiated Anticipation Medicine for Cardiovascular Disease: The National IMPACT Program Project.
    Prog Cardiovasc Dis. 2017 Nov 3. pii: S0033-0620(17)30142.
    PubMed     Abstract available

    September 2017
  84. HERMAN ME, O'Keefe JH, Bell DSH, Schwartz SS, et al
    Insulin Therapy Increases Cardiovascular Risk: Time for a Sea of Change in Type 2 Diabetes Treatment.
    Prog Cardiovasc Dis. 2017 Sep 25. pii: S0033-0620(17)30139.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.